Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.77 |
| ▸ | DRD4 | P21917 | 4/20 | 0.77 |
| ▸ | DRD3 | P35462 | 3/20 | 0.77 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.71 |
| ▸ | LMNA | P02545 | 4/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.70 |
| ▸ | MEN1 | O00255 | 7/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | GFER | P55789 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4003932 | 0.87 | DRD2 (1.00) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL26343148 | 0.86 | MEN1 (0.69) | DRD2DRD4DRD3ALDH1A1LMNA | |
| SCHEMBL4008925 | 0.85 | THRB (1.00) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL11001390 | 0.83 | DRD2 (0.68) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL4006361 | 0.83 | DRD2 (0.71) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL4007645 | 0.82 | ALDH1A1 (0.78) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL4006313 | 0.82 | THRB (0.77) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL26343157 | 0.82 | MEN1 (0.56) | DRD2DRD4DRD3ALDH1A1LMNA | |
| SCHEMBL4010416 | 0.81 | POLB (0.84) | DRD2DRD4DRD3THRBNPSR1 | |
| SCHEMBL4006366 | 0.81 | THRB (0.82) | DRD2DRD4DRD3THRBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303493-A1 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | SAN JOSE STATE UNIVERSITY RESEARCH FOUNDATION | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303493-A1 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | CAPG, SLC11A2, CAPRIN1 | DRD2 4359/4885DRD4 4279/4885DRD3 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.